Abstract “Neurodegenerative disease” is a term for a variety of disorders that primarily affect
neurons in the human brain and spinal cord. These diseases are presently incurable and …

The discovery of drugs for Alzheimer's disease (AD) therapy that can also permeate the
blood brain barrier (BBB) is very difficult owing to its specificity and restrictive nature. The …

The present study deals with preparation, optimization and in-vitro drug release study of
hydroxyapatite (HAp)-ofloxacin for bone-implantable delivery in osteomyelitis treatment. The …

A delivery system containing polymeric (Eudragit) nanoparticles has been developed for
encapsulation and controlled release of bioactive flavonoids (quercetin). Nanoparticles were …

This research report was to develop Cefixime loaded polylactide-co-glycolide (PLGA)
nanoparticles using modified precipitation method. TEM analysis indicated formation of well …

Drug delivery to the brain still remains highly challenging for the treatment of Alzheimer's
disease (AD). The development of new practical treatment modalities for the treatment of AD …

Among the materials for preparing the polymeric nanocarriers, poly (n-butylcyanoacrylate)(
PBCA), a polymer with medium length alkyl side chain, is of lower toxicity and proper …

This review article is to explore the utilization of biodegradable polymers and their
associated physicochemical properties in nano drug delivery (NDD). The main hub of the …

The purpose of this study was to optimize, characterize and develop microsponge drug
delivery system for topical delivery. Antibacterial compound, metronidazole was selected as …

Background: Alzheimer's disease (AD) is an age-related and irreversible neurological
disorder. The low efficacy of current therapeutic strategies is related to both poor drug …